A detailed history of Aufman Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Aufman Associates Inc holds 3,051 shares of ABT stock, worth $317,365. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,051
Previous 3,051 -0.0%
Holding current value
$317,365
Previous $335,000 3.28%
% of portfolio
0.24%
Previous 0.25%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $8,551 - $10,428
-75 Reduced 2.4%
3,051 $361,000
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $5,776 - $7,073
-50 Reduced 1.57%
3,126 $440,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $20,415 - $22,585
-175 Reduced 5.22%
3,176 $375,000
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $13,646 - $16,064
-129 Reduced 3.71%
3,351 $388,000
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $23,944 - $28,210
-220 Reduced 5.95%
3,480 $417,000
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $12,390 - $13,501
-118 Reduced 3.09%
3,700 $405,000
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $9,164 - $11,129
-100 Reduced 2.55%
3,818 $416,000
Q4 2019

Feb 06, 2020

BUY
$78.51 - $87.4 $307,602 - $342,433
3,918 New
3,918 $340,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aufman Associates Inc Portfolio

Follow Aufman Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aufman Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aufman Associates Inc with notifications on news.